Trademarkia Logo

Canada

C$
ALLARITY THERAPEUTICS
SEARCHED

on 13 Jun 2024

Last Applicant/ Owned by

Allarity Therapeutics, Inc.

24 School Street, 2nd FloorBoston MA 02108

US

Serial Number

2245730 filed on 28th Oct 2022

Correspondent Address

BENOÎT & CÔTÉ INC.

560 boul. Crémazie Est3e étageMontréal

QUEBEC

CA

H2P1E8

ALLARITY THERAPEUTICS

Trademark usage description

diagnostic preparations for scientific or research use in the field of cancer; diagnostic preparations other than for medical or veterinary purposes i Read More

Classification Information


Class [001]
Diagnostic preparations for scientific or research use in the field of cancer; diagnostic preparations other than for medical or veterinary purposes in the field of cancer; diagnostic reagents for scientific or research use in the field of cancer.


Classification kind code

11

Class [005]
Pharmaceuticals, medical and veterinary preparations, all in the field of cancer; diagnostic preparations for clinical or medical laboratory use, namely tumor profiling assays to aid in selecting cancer therapies; diagnostic preparations for clinical or medical laboratory use in the field of cancer.


Classification kind code

11

Class [042]
Medical research services and providing information relating thereto in the field of cancer research and disease classification; medical research services and providing information relating thereto in the field of cancer research and disease classification for medical research purposes; services of a chemical and/or biological laboratory in the field of cancer; scientific laboratory services in the field of cancer; medical laboratory services (scientific services) in the field of cancer; laboratory services in the field of scientific and medical research in the field of cancer; developing programs for simulating experiments or series of experiments in a virtual optical laboratory in the field of cancer; scientific and technological services and research and design relating thereto in the field of cancer; providing laboratory research services in the field of gene expression, namely in relation to cancer biology; scientific research for medical purposes in the field of cancer; design, development and programming of computer software for industrial analysis and research in the field of cancer; consultancy relating to research and development in the field of therapeutics; development of therapeutics, namely development in the pharmaceutical field of cancer.


Classification kind code

11

Class [044]
Preparation of reports relating to medical matters in the field of cancer; providing medical information in the field of cancer; medical diagnostic services, medical testing and medical information services, namely for cancer diagnosis, cancer research, research in diseases and disease classification for diagnostic and treatment purposes in the field of cancer; medical analysis for the diagnosis of cancer and prognosis of the expected progression of the disease; residential medical advice services in the field of cancer; medical services for the diagnosis of conditions of the human body in the field of cancer; medical analysis services in the field of cancer; medical advisory services in the field of cancer; medical testing services, namely being medical analysis services which detect gene mutations, gene expression profiles and other molecular indicators and markers to prognose disease and to predict disease progression, disease severity and therapy response for diagnostic and treatment purposes in the field of cancer; medical services in the field of cancer; veterinary services in the field of cancer; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services; therapy services, namely for the treatment of cancer; therapy services in the field of cancer; providing medical testing and medical information in the field of cancer.


Classification kind code

11

Mark Details


Serial Number

2245730

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 13th Jun 2024
Search Recorded
Submitted for opposition 20
on 13th Jun 2024
Examiner's First Report
Submitted for opposition 223
on 13th Jun 2024
Total Provisional Refusal
Submitted for opposition 256
on 16th Jan 2024
Notification of Possible Opposition Sent
Submitted for opposition 48
on 7th Jul 2023
Agent Changed
Submitted for opposition 257
on 16th Mar 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 15th Mar 2023
Created
Submitted for opposition 31
on 15th Mar 2023
Formalized
Submitted for opposition 30
on 28th Oct 2022
Filed
Submitted for opposition 228
on 28th Oct 2022
International Registration